All In MedTech

PMA device

Evolut FX+ TAV, Evolut FX DCS, Evolut FX LS

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

1

PMA pathway

Device trials

1

Naming "Evolut FX+ TAV"

MAUDE reports

0

Brand "Evolut FX+ TAV", since 2015

PubMed studies

0

Mentioning "Evolut FX+ TAV"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Evolut FX+ TAV, Evolut FX DCS, Evolut FX LS

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 1 of 1 decisions filed under this name.

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Evolut FX+ TAV", any status and sponsor, newest update first.

Open in Trial Radar
  • SMall Annuli Randomized To Evolut™ or SAPIEN™ TrialPivotal-lookingActive, not recruiting

    Medtronic CardiovascularPublic (MDT)

    NCT04722250 · 1,103 participants · Start Apr 2, 2021 · Primary completion Nov 10, 2023

    Device: Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems; Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems · For: Symptomatic Aortic Stenosis; Aortic Valve Stenosis; Aortic Valve Replacement

    Sites: La Jolla, California; Los Angeles, California; San Francisco, California · 92 sites in all

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Evolut FX+ TAV", and for the whole product code for context.

This brand

0 reports: 0 malfunction, 0 injury, 0 death

Whole product code NPT

77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death

Newest reports for this brand

No MAUDE reports name this brand.

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

1 more recall records with a free account

Published research

The most relevant PubMed records for "Evolut FX+ TAV"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code NPT.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.